The REG Iα/EDNRB axis promotes the malignant progression of CRC by activating Ca2+-dependent epithelial-mesenchymal transition, suggesting that targeting this axis is a promising therapeutic strategy to inhibit CRC metastasis.
Liu et al. (Wed,) studied this question.